Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Screening for prostate cancer.

Kotecha P. et al, (2025), BMJ, 389

Local anaesthetic transperineal biopsy versus transrectal prostate biopsy in prostate cancer detection (TRANSLATE): a multicentre, randomised, controlled trial.

Bryant RJ. et al, (2025), Lancet Oncol, 26, 583 - 595

IRE1 activity regulates tumour and microenvironment cell lineage states while stratifying localised and metastatic prostate cancer.

Doultsinos D. et al, (2025)

Protocol for a randomised phase 3 trial evaluating the role of Finasteride in Active Surveillance for men with low and intermediate-risk prostate cancer: the FINESSE Study.

Cumberbatch M. et al, (2025), BMJ Open, 15

Clonal phylogenies inferred from bulk, single cell, and spatial transcriptomic analysis of epithelial cancers.

Erickson A. et al, (2025), PLoS One, 20

Evidence for local anaesthetic transperineal biopsy versus transrectal prostate biopsy.

Lamb AD. et al, (2024), BMJ, 387

Clinical Implications of Basic Research: Exploring the Transformative Potential of Spatial 'Omics in Uro-oncology.

Figiel S. et al, (2024), Eur Urol

Prostate cancer detection after atypical small acinar proliferation (ASAP): A 10-year single-centre cohort.

Anbarasan T. et al, (2024), BJUI Compass, 5, 834 - 836

First-in-man study of the PSMA Minibody IR800-IAB2M for molecularly targeted intraoperative fluorescence guidance during radical prostatectomy.

Hamdy FC. et al, (2024), Eur J Nucl Med Mol Imaging, 51, 3009 - 3025

Molecular analysis of archival diagnostic prostate cancer biopsies identifies genomic similarities in cases with progression post-radiotherapy, and those with de novo metastatic disease.

Charlton PV. et al, (2024), Prostate, 84, 977 - 990

Identifying proteomic risk factors for overall, aggressive, and early onset prostate cancer using Mendelian Randomisation and tumour spatial transcriptomics.

Desai TA. et al, (2024), EBioMedicine, 105

Statistical analysis plan for the TRANSLATE (TRANSrectal biopsy versus Local Anaesthetic Transperineal biopsy Evaluation of potentially clinically significant prostate cancer) multicentre randomised controlled trial.

Marian IR. et al, (2024), Trials, 25

Perspectives on technology - prostate cancer: is local anaesthetic transperineal prostate biopsy really better than transrectal biopsy?

Berridge C. et al, (2024), BJU Int

Intra-prostatic tumour evolution, steps in metastatic spread and histogenomic associations revealed by integration of multi-region whole-genome sequencing with histopathological features.

Rao S. et al, (2024), Genome Med, 16

Spatial transcriptomic analysis of virtual prostate biopsy reveals confounding effect of tissue heterogeneity on genomic signatures.

Figiel S. et al, (2023), Mol Cancer, 22

Molecular analysis of archival diagnostic prostate cancer biopsies identifies genomic similarities in cases with progression post-radiotherapy, and those withde novometastatic disease

Charlton P. et al, (2023)

Genomic Evolution and Transcriptional Changes in the Evolution of Prostate Cancer into Neuroendocrine and Ductal Carcinoma Types.

Rao SR. et al, (2023), Int J Mol Sci, 24

Aligning germline and somatic mutations in prostate cancer. Are genetics changing practice?

Cussenot O. et al, (2023), BJU Int

Protocol for the TRANSLATE prospective, multicentre, randomised clinical trial of prostate biopsy technique.

Bryant RJ. et al, (2023), BJU Int, 131, 694 - 704

Re: Fifteen-year Outcomes After Monitoring, Surgery, or Radiotherapy for Prostate Cancer.

Sharma AD. et al, (2023), Eur Urol

Load More

1
2
3
4
5
6
7

Include forthcoming?